Resistance of CD1d-/- mice to ultraviolet-induced skin cancer is associated with increased apoptosis

American Journal of Pathology

Volumn 165, Issue 3, 2004, Pages 879-887

  Matsumura, Yasuhiro ^a   Moodycliffe, Angus M ^b   Nghiem, Dat X ^a   Ullrich, Stephen E ^a   Ananthaswamy, Honnavara N ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD1D ANTIGEN; GENOMIC DNA; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; EPIDERMIS; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KERATINOCYTE; KNOCKOUT MOUSE; MOUSE; NEWBORN; NICK END LABELING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; SKIN CANCER; SKIN FIBROBLAST; SUPPRESSOR CELL; TUMOR SUPPRESSOR GENE; ULTRAVIOLET IRRADIATION;

EID: 4344565067     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63350-0     Document Type: Article

References (44)

1. Gloster HM, Brodland DG: The epidemiology of skin cancer. Dermatol Surg 1996, 22:217-226
2. Strom S: Epidemiology of basal and squamous cell carcinomas of the skin. Basal and Squamous Cell Skin Cancers of the Head and Neck. Edited by R Weber, M Miller, H Goepfert. Baltimore, Williams and Wilkins, 1996, pp 1-7
3. Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, Halperin AJ, Ponten J: A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 1991, 88:10124-10128
4. Brash DE, Ziegler A, Jonason AS, Simon JA, Kunala S, Leffell DJ: Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion. J Invest Dermatol Symp Proc 1996, 1:136-142
5. Kanjilal S, Pierceall WE, Cummings KK, Kripke ML, Ananthaswamy HN: High frequency of p53 mutations in ultraviolet radiation-induced murine skin tumors: evidence for strand bias and tumor heterogeneity. Cancer Res 1993, 53:2961-2964
6. Matsumura Y, Ananthaswamy HN: Molecular mechanisms of photocarcinogenesis. Front Biosci 2002, 7:D765-D783
7. Porcelli SA, Modlin RL: The CD1d system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu Rev Immunol 1999, 17:297-329
8. Moody DB, Porcelli SA: Intracellular pathways of CD1d antigen presentation. Nat Rev Immunol 2002, 3:11-22
9. Exley M, Garcia J, Balk SP, Porcelli S: Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8+ T cells. J Exp Med 1997, 186:109-120
10. Brossay L, Chioda M, Burdin N, Koezuka Y, Casorati G, Dellabona P, Kronenberg M: CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J Exp Med 1998, 188:1521-1528
11. Chen YH, Chiu NM, Mandal M, Wang N, Wang CR: Impaired NK1+ T cell development and early IL-4 production in CD1d-deficient mice. Immunity 1997, 6:459-467
12. Mendiratta SK, Martin WD, Hong S, Boesteanu A, Joyce S, van Kaer L: CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 1997, 6:469-477
13. Moodycliffe AM, Nghiem D, Clydesdale G, Ullrich SE: Immune suppression and skin cancer development: regulation by NKT cells. Nat Immunol 2000, 1:521-525
14. Kripke M: Immunological effects of ultraviolet radiation. J Dermatol 1991, 18:429-433
15. Ouhtit A, Muller HK, Davis DW, Ullrich SE, McConkey D, Ananthaswamy HN: Temporal events in skin injury and the early adaptive responses in ultraviolet-irradiated mouse skin. Am J Pathol 2000, 156:201-207
16. Ouhtit A, Gorny A, Muller HK, Hill LL, Owen-Schaub L, Ananthaswamy HN: Loss of Fas-ligand expression in mouse keratinocyte during UV carcinogenesis. Am J Pathol 2000, 157:1975-1981
17. Ananthaswamy HN, Loughlin SM, Cox P, Evans RL, Ullrich SE, Kripke ML: Sunlight and skin cancer: inhibition of p53 mutations in UV-irradiated mouse skin by sunscreens. Nat Med 1997, 3:510-514
18. Hager B, Bickenbach JR, Fleckman P: Long-term culture of murine epidermal keratinocytes. J Invest Dermatol 1999, 112:971-976
19. Berg RJW, van Kranen HJ, Rebel HG, de Vries A, van Vloten WA, van Kreijl CF, van der Leun JC, de Gruijl FR: Early p53 alterations in mouse skin carcinogenesis by UVB radiation: immunohistochemical detection of mutant p53 protein in clusters of preneoplastic epidermal cells. Proc Natl Acad Sci USA 1996, 93:274-278
20. Rebel H, Mosnier LO, Berg RJW, Westerman-de Vries A, van Steeg H, van Kranen HJ, de Gruijl FR: Early p53-positive foci as indicators of tumor risk in ultraviolet-exposed hairless mice: kinetics of induction, effects of DNA repair deficiency, and p53 heterozygosity. Cancer Res 2001, 61:977-983
21. Jonason AS, Kunala S, Price GJ, Restifo RJ, Spirelli HM, Persing JA, Leffell DJ, Tarone RE, Brash DE: Frequent clones of p53-mutated keratinocytes in normal human skin. Proc Natl Acad Sci USA 1996, 93:14025-14029
22. Ziegler A, Jonason AS, Leffell DJ, Simon JA, Sharma HW, Kimmelman J, Remington L, Jacks T, Brash DE: Sunburn and p53 in the onset of skin cancer. Nature 1994, 372:773-776
23. Slaughter DP, Southwick HW, Smejkal W: Field cancerization in oral stratified squamous epithelium. Cancer 1953, 6:963-968
24. Braakhuis BJM, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH: A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 2003, 63:1727-1730
25. Kanjilal S, Strom SS, Clayman GL, Weber RS, el-Naggar AK, Kapur V, Cummings KK, Hill LA, Spitz MR, Kripke ML: p53 mutations in nonmelanoma skin cancer of the head and neck: molecular evidence for field cancerization. Cancer Res 1995, 55:3604-3609
26. Stern RS, Bolshakov S, Nataraj AJ, Ananthaswamy HN: p53 mutation in nonmelanoma skin cancers occurring in psoralen ultraviolet A-treated patients: evidence for heterogeneity and field cancerization. J Invest Dermatol 2002, 119:522-526
27. Ananthaswamy HN, Ullrich SE, Mascotto RE, Fourtanier A, Loughlin SM, Khaskina P, Bucana CD, Kripke ML: Inhibition of solar simulator-induced p53 mutations and protection against skin cancer development in mice by sunscreens. J Invest Dermatol 1999, 112:763-768
28. Willis RA: The evidence for field origin of skin tumors. Cancer Res 1945, 5:469-479
29. Slaughter DP, Southwick HW, Smejkal W: "Field cancerization" in oral stratified squamous epithelium. Cancer 1953, 6:963-968
30. Lydiatt WM, Anderson PE, Bazzana T, Casale M, Hughes CJ, Huvos AG, Lydiatt DD, Schantz SP: Molecular support for field cancerization in the head and neck. Cancer 1998, 82:1376-1380
31. Fidler IJ: Critical factors in the biology of human cancer metastasis. 28th G.H.A. Clowes Memorial Award Lecture. Cancer Res 1990, 50:6130-6138
32. Li G, Tron V, Ho V: Induction of squamous cell carcinoma in p53-deficient mice after ultraviolet irradiation. J Invest Dermatol 1998, 110:72-75
33. Jiang W, Ananthaswamy HN, Muller HK, Kripke ML: p53 protects against skin cancer induction by UV-B radiation. Oncogene 1999, 18:4247-4253
34. Cho SH, Delehedde M, Rodriguez-Vallanueva J, Brisbay S, McDonnell TJ: Bax gene disruption alters the epidermal response to ultraviolet irradiation and in vivo induced skin carcinogenesis. Int J Mol Med 2001, 7:235-241
35. Hildesheim J, Bulavin DV, Anver MR, Alvord WG, Hollander MC, Vardanian L, Fornace Jr AJ: gadd45a protects against UV irradiation-induced skin tumors, and promotes apoptosis and stress signaling via MAPK and p53. Cancer Res 2002, 62:7305-7315
36. Tiano HF, Loftin CD, Akunda J, Lee CA, Spalding J, Sessoms A, Dunson DB, Rogan EG, Morham SG, Smart RC, Langenbach R: Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis. Cancer Res 2002, 62:3395-3401
37. Oren M, Damalas A, Gottlieb T, Michael D, Japlick J, Ferunando J, Leal M, Maya R, Moas M, Seger R, Taya Y, Ben-Ze'Ev A: Regulation of p53: intricate loops and delicate balances. Biochem Pharmacol 2002, 64:865-871
38. Kamijo T, Weber JD, Zambetti G: Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc Natl Acad Sci USA 1998, 95:8292-8297
39. Pomerantz J, Schreiber-Angus N, Liegeous NJ: The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 1998, 92:713-723
40. Honda R, Yasuda H: Association of p19(ARF) with MDM2 inhibits ubiquitin ligase activity of MDM2 for tumor suppressor p53. EMBO J 1999, 18:22-27
41. Tao W, Levine AJ: p19(ARF) stabilizes p53 by blocking nucleocytoplasmic shuttling of Mdm2. Proc Natl Acad Sci USA 1999, 96:6937-6941
42. Weber JD, Taylor LJ, Roussel MF, Sherr CJ, Bar-Sagi D: Nucleolar Arf sequesters Mdm2 and activates p53. Nat Cell Biol 1999, 1:20-26
43. Nickoloff BJ, Wrone-Smith T, Bonish B, Porcelli SA: Response of murine and normal human skin injection of allogeneic blood-derived psoriatic immunocytes. Arch Dermatol 1999, 135:546-552
44. Bonish B, Jullien D, Dutronc Y, Huang BB, Modlin R, Spada FM, Porcelli SA, Nickoloff BJ: Overexpression of CD1d by keratinocytes in psoriasis and CD1d-dependent IFN-gamma production by NK-T cells. J Immunol 2000, 165:4076-4085.